Your browser doesn't support javascript.
loading
Risk of Mild Cognitive Impairment or Probable Dementia in New Users of Angiotensin II Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors: A Secondary Analysis of Data From the Systolic Blood Pressure Intervention Trial (SPRINT).
Cohen, Jordana B; Marcum, Zachary A; Zhang, Chong; Derington, Catherine G; Greene, Tom H; Ghazi, Lama; Herrick, Jennifer S; King, Jordan B; Cheung, Alfred K; Bryan, Nick; Supiano, Mark A; Sonnen, Joshua A; Weintraub, William S; Scharfstein, Daniel; Williamson, Jeff; Pajewski, Nicholas M; Bress, Adam P.
Afiliação
  • Cohen JB; Department of Medicine, Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Marcum ZA; Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Zhang C; Department of Pharmacy, University of Washington School of Pharmacy, Seattle.
  • Derington CG; Intermountain Healthcare Department of Population Health Sciences, Division of Biostatistics, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.
  • Greene TH; Intermountain Healthcare Department of Population Health Sciences, Division of Health System Innovation and Research, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.
  • Ghazi L; Intermountain Healthcare Department of Population Health Sciences, Division of Health System Innovation and Research, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.
  • Herrick JS; Clinical and Translational Research Accelerator, Yale University School of Medicine, New Haven, Connecticut.
  • King JB; Intermountain Healthcare Department of Population Health Sciences, Division of Health System Innovation and Research, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.
  • Cheung AK; George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, Utah.
  • Bryan N; Intermountain Healthcare Department of Population Health Sciences, Division of Health System Innovation and Research, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.
  • Supiano MA; Institute for Health Research, Kaiser Permanente Colorado, Aurora.
  • Sonnen JA; Department of Internal Medicine, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.
  • Weintraub WS; Medical Service, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, Utah.
  • Scharfstein D; Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
  • Williamson J; Geriatrics Division, Spencer Fox Eccles School of Medicine, University of Utah, Salt Lake City.
  • Pajewski NM; Departments of Pathology, Neurology, and Neurosurgery, McGill University, Montréal, Québec, Canada.
  • Bress AP; MedStar Health Research Institute and Georgetown University, Washington, DC.
JAMA Netw Open ; 5(7): e2220680, 2022 07 01.
Article em En | MEDLINE | ID: mdl-35834254
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Demência / Disfunção Cognitiva Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Demência / Disfunção Cognitiva Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Male Idioma: En Ano de publicação: 2022 Tipo de documento: Article